Concepedia

Gabi Schutzius

GS

6

Publications

135

Citations

6

H-Index

2013

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Gabi Schutzius is an author at Novartis (Switzerland) specializing in cell signaling, medicine, and cell biology.

ORCID

Top concepts

Publications per year

2013–2024

6

Publications

6

IRF2 is a master regulator of human keratinocyte stem cell fate

Nicolas Mercado, Gabi Schutzius, Christian Kolter et al. · Nature Communications · 2019 · 37 citations · Full text

NIBR-LTSi is a selective LATS kinase inhibitor activating YAP signaling and expanding tissue stem cells in vitro and in vivo

Kenji Namoto, Clara Baader, Vanessa Orsini et al. · Cell stem cell · 2024 · 27 citations

, , +10

A quantitative homogeneous assay for fragile X mental retardation 1 protein

Gabi Schutzius, Dorothée Bleckmann, Sandra Kapps-Fouthier et al. · Journal of Neurodevelopmental Disorders · 2013 · 26 citations · Full text

Human Cytomegalovirus pUL47 Modulates Tegumentation and Capsid Accumulation at the Viral Assembly Complex

Ilaria Cappadona, Clarissa Villinger, Gabi Schutzius et al. · Journal of Virology · 2015 · 22 citations · Full text

BET bromodomain inhibitors regulate keratinocyte plasticity

Gabi Schutzius, Christian Kolter, Sebastian Bergling et al. · Nature Chemical Biology · 2021 · 13 citations

, , +3

Rows per page

1–5 of 6